GIC
DGX icon

Generali Investments CEE’s Quest Diagnostics DGX Stock Holding History

Generali Investments CEE’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Hold
6,000
– – 0.06% 259
2026
Q1 		$1.18M Hold
6,000
– – 0.06% 266
2025
Q4 		$1.04M Buy
6,000
+1,500
+33% +$273K 0.07% 244
2025
Q3 		$858K Hold
4,500
– – 0.07% 253
2025
Q2 		$808K Hold
4,500
– – 0.07% 256
2025
Q1 		$761K Hold
4,500
– – 0.07% 250
2024
Q4 		$679K Buy
+4,500
New +$700K 0.07% 236

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Generali Investments CEE's DGX Position: Q2 2026 in Review

Generali Investments CEE held its Quest Diagnostics (DGX) position steady in Q2 2026 at 6,000 shares worth $1.27M. The position accounts for 0.06% of the portfolio, ranked #259.

Generali Investments CEE first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Generali Investments CEE held 6,000 shares of Quest Diagnostics worth $1.27M as of Q2 2026.
  • Generali Investments CEE left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.06% of Generali Investments CEE's portfolio in Q2 2026, its #259 holding.
  • Generali Investments CEE first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.